Literature DB >> 10455271

Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.

M Lysíková1, K Fuksová, T Elbert, J Jakubík, S Tucek.   

Abstract

Seven esters of alpha-truxillic acid have been synthesized: bis-3-piperidylpropyl ester and its quaternary bis-N-ethyl derivative, bis-N-diethylaminopropyl ester and its quaternary bis-N-methyl derivative, and bis-4-piperidylbutyl ester and its quaternary bis-N-methyl and bis-N-ethyl derivatives. All esters inhibited the specific binding of muscarinic receptor antagonist [methyl-3H]-N-methylscopolamine ([3H]-NMS) to muscarinic receptors in membranes of CHO cell lines stably expressing the human gene for the M1, M2, M3 or M4 subtype of muscarinic receptors. All esters displayed the highest potency at the M2 and the lowest potency at the M3 receptor subtype. In experiments performed on the M2 muscarinic receptor subtype, the affinity between the receptors and the esters was greatly increased when the concentration of ions was diminished. The highest affinities were found for the tertiary bis-3-piperidylpropyl and bis-4-piperidylbutyl aminoesters (equilibrium dissociation constants of 52 and 179 pM, respectively, in the low ionic strength medium). All investigated esters slowed down the dissociation of [3H]-NMS from the M2 muscarinic receptor subtype. [3H]-NMS dissociation from the M1, M3 and M4 muscarinic receptor subtypes was investigated in experiments with the bis-4-piperidylbutyl aminoester and also found to be decelerated. It is concluded that the esters of alpha-truxillic acid act as M2-selective allosteric modulators of muscarinic receptors and that, by their potency, the tertiary bis-3-piperidylpropyl and bis-4-piperidylbutyl aminoesters surpass the other known allosteric modulators of these receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455271      PMCID: PMC1566119          DOI: 10.1038/sj.bjp.0702646

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Allosteric antagonists of the muscarinic acetylcholine receptor.

Authors:  N H Lee; E E el-Fakahany
Journal:  Biochem Pharmacol       Date:  1991-07-05       Impact factor: 5.858

2.  Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Authors:  E K Pedder; P Eveleigh; D Poyner; E C Hulme; N J Birdsall
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

Authors:  F J Ehlert
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

4.  Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.

Authors:  N J Buckley; T I Bonner; C M Buckley; M R Brann
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

5.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.

Authors:  J Proska; S Tucek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

6.  Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.

Authors:  M Waelbroeck
Journal:  Mol Pharmacol       Date:  1994-10       Impact factor: 4.436

7.  Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.

Authors:  J Nedoma; S Tucek; A F Danilov; S A Shelkovnikov
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

8.  Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.

Authors:  J Jakubík; S Tucek
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

9.  Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.

Authors:  H Matsui; S Lazareno; N J Birdsall
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

10.  Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.

Authors:  J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more
  4 in total

1.  Nickel-Catalyzed Reductive [2+2] Cycloaddition of Alkynes.

Authors:  Santiago Cañellas; John Montgomery; Miquel À Pericàs
Journal:  J Am Chem Soc       Date:  2018-12-10       Impact factor: 15.419

2.  Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.

Authors:  M Lysíková; Z Havlas; S Tucek
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

Review 3.  Allosteric Modulation of Muscarinic Acetylcholine Receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

4.  Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Doležal
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.